MiniArc Study: Long-Term Effectiveness Trial for AMS Sling Systems
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Multi-center, prospective, single arm study. Qualify patients will receive treatment for stress urinary incontinence by implantation of an AMS Sling System. The study is a long-term evaluation of effectiveness and safety associated with AMS sling systems.
| Condition | Intervention | Phase |
|---|---|---|
|
Stress Urinary Incontinence in Women |
Device: MiniArc |
Phase 4 |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Long-Term Effectiveness Trial for AMS Sling Systems |
- Evaluation of long-term effectiveness after implantation of MiniArc sling via qualitative(i.e.UDI-6 and IIQ-7) and quantitative measurement (i.e.pad weight test and cough stress test) in females for treatment of SUI in general post-market use. [ Time Frame: 2 years ] [ Designated as safety issue: No ]
- Evaluation of procedural variables of the implantation,outcomes,and long-term safety.These outcomes will be measured via questionnaires, procedural data, and report of adverse events. [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]
| Enrollment: | 188 |
| Study Start Date: | September 2007 |
| Estimated Study Completion Date: | November 2010 |
| Estimated Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |
-
Device: MiniArc
This study is a post market study to evaluate variables of the implantation, safety, and outcomes in a representative population (SUI) indicated for AMS sling systems at various time points. The study duration is 2 year with an estimated 200 enrollment. The outcomes of the treatment will be evaluated via pad weight test, cough stress test, QoLs,and other patient administered questionnaires.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Females 18 years or older who have confirmed SUI
Inclusion Criteria:
- Females 18 years or older who have confirmed SUI defined as involuntary loss of urine that occurs during physical activity, such as coughing, sneezing, laughing, or exercise.
Exclusion Criteria:
- Unwilling or unable to sign ICF
- Unable to understand the study or has a history of non-compliance with medical devices
- Contradicted for the implantation surgery due to the following: renal sufficiency, urethral diverticulum, fistula, significant prolapse conditions, pregnant, pelvic cancer, compromise immune system,vulvar pain,blood coagulation disorder, and chronic abscesses
- Pelvic prolapse greater than grade 3
- Is, in the investigator's opinion, otherwise unsuitable for the study
Contacts and Locations| United States, North Carolina | |
| McKay Urology Research | |
| Charlotte, North Carolina, United States, 28207 | |
| Principal Investigator: | Michael Kennelly, MD | McKay Urology Research |
More Information
No publications provided
| Responsible Party: | Audrey Singh- Clinical Project Lead, American Medical Systems, Inc. |
| ClinicalTrials.gov Identifier: | NCT00541151 History of Changes |
| Other Study ID Numbers: | WC0605 |
| Study First Received: | October 5, 2007 |
| Last Updated: | August 26, 2010 |
| Health Authority: | United States: Western Institutional Review Board and Local Institution Review Boards UK: South Glasgow and Clyde Research Ethics Committee Europe: Commissie voor Medische Ethiek Klinisch Onderzoek Canada:VIHA ethics committee |
Keywords provided by American Medical Systems:
|
Stress urinary incontinence in Women |
Additional relevant MeSH terms:
|
Urinary Incontinence Urinary Incontinence, Stress Urination Disorders |
Urologic Diseases Urological Manifestations Signs and Symptoms |
ClinicalTrials.gov processed this record on May 16, 2013